Evidence map›Paper›PMID 32917457›Full record

ReviewJournal of voice : official journal of the Voice Foundation2021

Terapia de voz en el contexto de la pandemia covid-19; recomendaciones para la práctica clínica.

Adrián Castillo-Allendes, Francisco Contreras-Ruston, Lady Cantor, Juliana Codino, Marco Guzman, Celina Malebran, Carlos Manzano, Axel Pavez, Thays Vaiano, Fabiana Wilder and 1 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of voice : official journal of the Voice Foundation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 11 institutions in 6 countries.

Adrián Castillo-AllendesDepartment of Communicative Sciences and Disorders, Michigan State University, East Lansing, Michigan.
Francisco Contreras-RustonSpeech-Language Pathology and Audiology Department, Universidad de Valparaíso, San Felipe, Chile. Electronic address: Francisco.contreras@uv.cl.
Lady CantorDepartment of Collective Health, Universidad Nacional de Colombia, Bogotá, Colombia; Program of Speech and Language Pathology, Universidad Manuela Beltrán, Bogotá, Colombia.
Juliana CodinoDepartment of Communicative Sciences and Disorders, Michigan State University, East Lansing, Michigan; Lakeshore Professional Voice Center, Lakeshore Ear, Nose, and Throat Center, St. Clair Shores, Michigan.
Marco GuzmanUniversidad de los Andes, Chile, Santiago, Chile.
Celina MalebranEscuela de Fonoaudiología, Universidad Católica Silva Henríquez, Santiago, Chile.
Carlos ManzanoHospital Médica Sur, Ciudad de México, México; Centro Médico ABC, Ciudad de México, México.
Axel PavezPhysical Medicine and Rehabilitation Service, Hospital de Urgencia Asistencia Pública. Santiago, Chile.
Thays VaianoCEV - Centro de Estudos da Voz, São Paulo, Brazil; Speech-Language Pathology and Audiology Department, Escola Paulista de Medicina, Federal University of São Paulo, São Paulo, Brazil.
Fabiana WilderCarrera de Fonoaudiología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina; Servicio de Fonoudiología, Hospital de Clínicas "José de San Martin", Buenos Aires, Argentina.
Mara BehlauCEV - Centro de Estudos da Voz, São Paulo, Brazil; Speech-Language Pathology and Audiology Department, Escola Paulista de Medicina, Federal University of São Paulo, São Paulo, Brazil.
Centro de Estudos da Voz · BRHospital de Clínicas "José de San Martín" · ARHospital Dipreca · CLHospital Médica Sur · MXLakeshore Foundation · USMichigan State University · USUniversidad Católica Silva Henríquez · CLUniversidad de Los Andes, Chile · CLUniversidade Federal de São Paulo · BRUniversidad Manuela Beltrán · COUniversity of Valparaíso · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSince the beginning of the new pandemic, COVID-19 health services have had to face a new scenario. Voice therapy faces a double challenge, interventions using telepractice, and delivering rehabilitation services to a growing population of patients at risk of functional impairment related to the COVID-19 disease. Moreover, as COVID-19 is transmitted through droplets, it is critical to understand how to mitigate these risks during assessment and treatment.

objectiveTo promote safety, and effective clinical practice to voice assessment and rehabilitation in the pandemic COVID-19 context for speech-language pathologists.

methodsA group of 11 experts in voice and swallowing disorders from 5 different countries conducted a consensus recommendation following the American Academy of Otolaryngology-Head and Neck Surgery rules building a clinical guide for speech-language pathologists during this pandemic context.

resultsThe clinical guide provides 79 recommendations for clinicians in the management of voice disorders during the pandemic and includes advice from assessment, direct treatment, telepractice, and teamwork. The consensus was reached 95% for all topics.

conclusionThis guideline should be taken only as recommendations; each clinician must attempt to mitigate the risk of infection and achieve the best therapeutic results taking into account the patient's particular reality.

Indexed as

COVID-19HumansPandemicsSARS-CoV-2United StatesCOVID-19–Phoniatrics–Speech-language pathology–Telepractice–Voice disorders–Voice therapy

Identifiers

PMID32917457
PMCPMC7442931
OpenAlexW3080995770

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.